CHICAGO, June 07, 2019 (GLOBE NEWSWIRE) -- Tolmar Pharmaceuticals Inc., a fully integrated specialty pharmaceutical company, today announced new formulary placement for ELIGARD ® with Rite-Aid’s ...
You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: I am 63 and was diagnosed with aggressive prostate cancer in ...
Tolmar will resume the rights to ELIGARD® in the Canadian Market from Sanofi Canada BUFFALO GROVE, Ill., Oct. 8, 2021 /PRNewswire/ -- Tolmar, a specialty pharmaceutical company, today announced that, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results